美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

美國抗疫概念

1,480.06

+12.920.88%

漲家數：10

跌家數：10

平家數：- -

市盈率：- -

高：1,487.39

開：1,467.14

低：1,462.61

收：1,467.14

資料載入中...

Nanoviricides, Inc.盤中異動下午盤大幅跳水5.33%報1.42美元

【歐股“十一羅漢”｜諾和諾德收漲超1.4%，阿斯麥漲約0.5%】週一，阿斯麥控股荷蘭阿姆斯特丹股價收漲0.48%，報713.50歐元。諾和諾德哥本哈根股價收漲1.46%，報639.20。雀巢收漲3.15%，葛蘭素史克漲1.65%，阿斯利康、歐萊雅、諾華、德國思愛普Sap漲0.55%-0.26%。羅氏製藥和賽諾菲則至多收跌0.71%，LVMH集團跌1.47%。此外，歐洲芯片概念股普跌，BE半導體實業收跌2.17%，英飛凌、意法半導體至多跌1.29%，德國愛思強則漲1.76%。

輝瑞任命前 FDA 總監 Patrizia Cavazzoni 為首席醫療官

雷克蘭醫療工業盤中異動股價大跌5.17%報23.44美元

Alpha Pro Tech, Ltd.盤中異動早盤急速下跌5.52%

Ocugen, Inc.盤中異動早盤股價大跌5.15%

Equillium, Inc.盤中異動股價大跌5.44%

伊諾維奧製藥盤中異動早盤股價大跌5.36%報2.12美元

諾瓦瓦克斯醫藥盤中異動早盤急速跳水5.07%

Summit/康方生物一雙抗產品與輝瑞達成合作

每日经济新闻

Ibio, Inc.盤中異動早盤股價大漲5.17%

Co-Diagnostics, Inc.盤中異動早盤股價大跌5.25%報0.668美元

莫德納盤中異動股價大跌5.12%報33.71美元

上市近一年未有銷售，慘遭輝瑞放棄

佰傲谷BioValley

一圖解碼：真實生物二度赴港IPO 阿茲夫定撐起主營收虧損大幅收窄

吉利德科學(GILD.US)突破性小分子藥物獲歐盟批准用於治療致命性肝病

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1480.0557,"timestamp":1741381199999,"preClose":1467.1393,"halted":0,"volume":126573383,"delay":0,"changeRate":0.008804,"change":12.916382,"pbRate":4.037358,"amount":7265241469.443725,"amplitude":0.016884,"prevYearClose":1274.8187,"fiveDayClose":1463.5875,"twentyDayClose":1359.8558,"turnoverRate":0.008184,"marketCap":1220494102080,"floatMarketCap":1198623322288,"peRate":31.999995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1487.3851,"amplitude":0.016884,"preClose":1467.1393,"low":1462.6143,"pbRate":"4.037358","latestPrice":1480.0557,"volume":126573383,"delay":0,"open":1467.1393,"prevYearClose":1274.8187,"prevWeekClose":1463.5875,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1463.5875,"twentyDayClose":1359.8558,"sixtyDayClose":1300.6962,"secType":"PLATE","market":"US","turnoverRate":0.008184,"peRate":31.999995,"marketCap":1220494102080,"floatMarketCap":1198623322288,"timestamp":1741381199999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":10,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514771067","title":"Nanoviricides, Inc.盤中異動 下午盤大幅跳水5.33%報1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514771067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514771067?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 02:48","pubTimestamp":1740422900,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时48分，Nanoviricides, Inc.股票出现波动，股价快速跳水5.33%。Nanoviricides, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Pepgen Inc.、Nutriband Inc C/Wts 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为317.51%、133.85%、39.06%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Nanoviricides, Inc.公司简介：Nanoviricides Inc是一家纳米生物制药公司，致力于发现、开发和商业化治疗剂，以推进对患有危及生命的病毒感染患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225024820962ecd49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225024820962ecd49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NNVC","BK4568","BK4139"],"gpt_icon":0},{"id":"2514666774","title":"【歐股“十一羅漢”｜諾和諾德收漲超1.4%，阿斯麥漲約0.5%】週一，阿斯麥控股荷蘭阿姆斯特丹股價收漲0.48%，報713.50歐元。諾和諾德哥本哈根股價收漲1.46%，報639.20。雀巢收漲3.15%，葛蘭素史克漲1.65%，阿斯利康、歐萊雅、諾華、德國思愛普Sap漲0.55%-0.26%。羅氏製藥和賽諾菲則至多收跌0.71%，LVMH集團跌1.47%。此外，歐洲芯片概念股普跌，BE半導體實業收跌2.17%，英飛凌、意法半導體至多跌1.29%，德國愛思強則漲1.76%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514666774","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514666774?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 01:50","pubTimestamp":1740419418,"startTime":"0","endTime":"0","summary":"周一，阿斯麦控股荷兰阿姆斯特丹股价收涨0.48%，报713.50欧元。诺和诺德哥本哈根股价收涨1.46%，报639.20。雀巢收涨3.15%，葛兰素史克涨1.65%，阿斯利康、欧莱雅、诺华、德国思爱普Sap涨0.55%-0.26%。罗氏制药和赛诺菲则至多收跌0.71%，LVMH集团跌1.47%。此外，欧洲芯片概念股普跌，BE半导体实业收跌2.17%，英飞凌、意法半导体至多跌1.29%，德国爱思强则涨1.76%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"be3201d4ba339139b8fa1c56337988b2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25015048358625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4007","01477","LU2063271972.USD","LU2236285917.USD","AZN","LU0444973449.USD","03165","BK4585","IE00B2B36J28.USD","159582","LU1829250122.USD","LU0823434740.USD","BK4182","IE00BZ1G4Q59.USD","BK4605","LU0097036916.USD","LU1093756168.USD","BK4578","LRLCY","LU1093756325.SGD","BK4568","IE00BFTCPJ56.SGD","BK4541","IE00BJJMRZ35.SGD","BK4141","BE","LU1815336760.USD","LU2506951792.HKD","STM","BK4147","159813","LU0109394709.USD","LU0823434583.USD","NVS","LU2417539215.USD","NVO","BK4212","GSK.UK","BK4599","IE0004445239.USD","GSK","ASML","LU2294711713.HKD","NSRGY","IE00BMPRXN33.USD","BK4554","LU0211331839.USD","IE00BD6J9T35.USD","LU1642822529.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2514755647","title":"輝瑞任命前 FDA 總監 Patrizia Cavazzoni 為首席醫療官","url":"https://stock-news.laohu8.com/highlight/detail?id=2514755647","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514755647?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 00:13","pubTimestamp":1740413621,"startTime":"0","endTime":"0","summary":"辉瑞任命前 FDA 总监 Patrizia Cavazzoni 为首席医疗官路透社2月24日 - 辉瑞PFE.N周一表示，美国食品及药物管理局药物中心前负责人帕特里齐亚-卡瓦佐尼将加入该公司，担任首席医疗官。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3T3PF182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","IE0002270589.USD","LU1023059063.AUD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4534","LU0122379950.USD","LU1894683264.USD","BK4592","IE00BLSP4239.USD","BK4588","LU1894683348.USD","LU0289739699.SGD","LU0868494617.USD","LU1066053197.SGD","SG9999013999.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999011175.SGD","LU0321505439.SGD","SG9999001176.SGD","BK4007","IE00B19Z3581.USD","LU0306806265.USD","LU1066051498.USD","LU0321505868.SGD","BK4585","LU1883839398.USD","LU0170899867.USD","LU0306807586.USD","LU0225284248.USD","SG9999002232.USD","BK4581","IE00B19Z3B42.SGD","SG9999003800.SGD","IE000M9KFDE8.USD","BK4568","LU0058720904.USD","SGXZ57979304.SGD","SG9999001176.USD","LU0225771236.USD","LU0456855351.SGD","PFE","BK4533","BK4599","LU0985481810.HKD","LU0234572021.USD"],"gpt_icon":0},{"id":"2514677649","title":"雷克蘭醫療工業盤中異動 股價大跌5.17%報23.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514677649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514677649?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 00:09","pubTimestamp":1740413375,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时09分，雷克兰医疗工业股票出现波动，股价大幅跳水5.17%。截至发稿，该股报23.44美元/股，成交量1.4979万股，换手率0.16%，振幅4.80%。雷克兰医疗工业股票所在的服装制造行业中，整体跌幅为0.91%。雷克兰医疗工业公司简介：美国雷克兰工业公司为工业防护服市场制造和销售安全服装和配件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000936a2522b6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000936a2522b6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LAKE","BK4568","IE00B66KJ199.SGD","BK4202","IE00B7SZL793.SGD","IE00B19Z4B17.USD","IE0031619046.USD"],"gpt_icon":0},{"id":"2514828775","title":"Alpha Pro Tech, Ltd.盤中異動 早盤急速下跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514828775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514828775?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 23:52","pubTimestamp":1740412334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时52分，Alpha Pro Tech, Ltd.股票出现波动，股价快速下跌5.52%。Alpha Pro Tech, Ltd.股票所在的建筑设备行业中，整体跌幅为0.67%。其相关个股中，开利全球、Latham Group, Inc.、Janus International Group, Inc.涨幅较大，Scantech Ai Systems Inc.、羚羊控股、Aspen Aerogels, Inc.较为活跃，换手率分别为12.85%、6.39%、0.94%，振幅较大的相关个股有Scantech Ai Systems Inc.、Airjoule Technologies Corp C/Wts 15/03/2029、羚羊控股，振幅分别为30.38%、17.42%、13.17%。Alpha Pro Tech, Ltd.公司简介：Alpha Pro Tech Ltd主要在美国从事一次性防护服、建筑用品和感染控制产品的开发、制造和营销业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235214962eab89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235214962eab89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","APT","BK4086"],"gpt_icon":0},{"id":"2513720477","title":"Ocugen, Inc.盤中異動 早盤股價大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513720477?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 23:05","pubTimestamp":1740409557,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分，Ocugen, Inc.股票出现异动，股价急速下挫5.15%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为163.54%、71.44%、25.67%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230557abdb166c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230557abdb166c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","OCGN","BK4563"],"gpt_icon":0},{"id":"2513720385","title":"Equillium, Inc.盤中異動 股價大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513720385?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:59","pubTimestamp":1740409191,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时59分，Equillium, Inc.股票出现波动，股价快速下挫5.44%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为150.95%、65.71%、25.12%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225951a2521b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225951a2521b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2513720448","title":"伊諾維奧製藥盤中異動 早盤股價大跌5.36%報2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513720448?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:57","pubTimestamp":1740409045,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时57分，伊诺维奥制药股票出现波动，股价急速跳水5.36%。截至发稿，该股报2.12美元/股，成交量17.1021万股，换手率0.47%，振幅5.80%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.22%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225725962e9f59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225725962e9f59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","INO","BK4583"],"gpt_icon":0},{"id":"2513720440","title":"諾瓦瓦克斯醫藥盤中異動 早盤急速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513720440?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:48","pubTimestamp":1740408485,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时48分，诺瓦瓦克斯医药股票出现波动，股价急速下跌5.07%。截至发稿，该股报7.59美元/股，成交量137.393万股，换手率0.86%，振幅4.26%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，33%的券商给予持有建议，17%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为0.02%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224805abdb1221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224805abdb1221&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4547","BK4568","NVAX","BK4585"],"gpt_icon":0},{"id":"2513727501","title":"Summit/康方生物一雙抗產品與輝瑞達成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727501","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513727501?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:41","pubTimestamp":1740408113,"startTime":"0","endTime":"0","summary":"2月24日，SummitTherapeutics宣布与辉瑞开展临床试验合作，以评估PD-1/VEGF双特异性抗体Ivonescimab（依沃西单抗，康方生物原研）与辉瑞的多种抗体偶联药物（ADCs）联合用于多种实体瘤的疗效和安全性。根据协议条款，Summit将提供用于拟议研究的Ivonescimab，辉瑞将负责开展研究的运营工作。这些研究将由Summit和辉瑞共同监督。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502243328032382.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502243328032382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1894683348.USD","LU2488822045.USD","LU1066051498.USD","LU0321505439.SGD","SG9999001176.USD","LU0058720904.USD","LU0348784397.USD","SG9999002232.USD","SG9999001176.SGD","LU0234572021.USD","IE00B543WZ88.USD","SGXZ57979304.SGD","LU1023059063.AUD","BK4585","BK4568","LU1066053197.SGD","IE0002270589.USD","LU0456855351.SGD","09926","LU0122379950.USD","LU0289739699.SGD","SG9999011175.SGD","BK1574","IE00B19Z3581.USD","LU0348783233.USD","LU0417516571.SGD","LU1057294990.SGD","BK4534","LU1720050803.USD","LU1794554557.SGD","LU1894683264.USD","SG9999013999.USD","LU0170899867.USD","LU0985481810.HKD","LU0225771236.USD","IE00BBT3K403.USD","LU0868494617.USD","IE00BPRC5H50.USD","BK1161","LU1883839398.USD","SG9999003800.SGD","BK4592","LU0306807586.USD","SG9999002224.SGD","IE000M9KFDE8.USD","BK4007","IE00B5MMRT66.SGD","BK4588","BK4550"],"gpt_icon":0},{"id":"2513727532","title":"Ibio, Inc.盤中異動 早盤股價大漲5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513727532?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:38","pubTimestamp":1740407901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时38分，Ibio, Inc.股票出现波动，股价大幅上涨5.17%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为52.60%、46.77%、24.53%，振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Gossamer Bio, Inc.，振幅分别为92.70%、21.42%、14.69%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223822962e9a43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223822962e9a43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","IBIO"],"gpt_icon":0},{"id":"2513727379","title":"Co-Diagnostics, Inc.盤中異動 早盤股價大跌5.25%報0.668美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513727379?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:31","pubTimestamp":1740407501,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Co-Diagnostics, Inc.股票出现异动，股价快速下挫5.25%。截至发稿，该股报0.668美元/股，成交量2.3874万股，换手率0.07%，振幅1.32%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体跌幅为0.19%。其相关个股中，Envoy Medical, Inc.、Senseonics Holdings, Inc.、Intelligent Bio Solutions Inc.涨幅较大，Vivos Therapeutics, Inc.、Reshape Lifesciences, Inc.、Sintx Technologies, Inc.较为活跃，换手率分别为8.65%、5.75%、4.84%，振幅较大的相关个股有Lucid Diagnostics Inc.、Sintx Technologies, Inc.、Nexalin Technology, Inc.，振幅分别为20.55%、5.97%、5.87%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223141962e9880&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223141962e9880&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2513727372","title":"莫德納盤中異動 股價大跌5.12%報33.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513727372?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:31","pubTimestamp":1740407479,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，莫德纳股票出现波动，股价快速下跌5.12%。截至发稿，该股报33.71美元/股，成交量70.7841万股，换手率0.18%，振幅0.42%。莫德纳股票所在的生物技术行业中，整体跌幅为0.12%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223120962e9859&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223120962e9859&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4139","BK4548","BK4588","BK4551","BK4501","BK4532","BK4585","BK4533","MRNA","BK4568"],"gpt_icon":1},{"id":"2513718706","title":"上市近一年未有銷售，慘遭輝瑞放棄","url":"https://stock-news.laohu8.com/highlight/detail?id=2513718706","media":"佰傲谷BioValley","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513718706?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 12:02","pubTimestamp":1740369720,"startTime":"0","endTime":"0","summary":"近日，根据媒体报道，辉瑞的一位发言人证实，辉瑞正在停止其血友病B基因治疗药物Beqvez的所有的开发和商业化活动。同时，辉瑞发言人证实，自获批以来，未有商业患者接受过Beqvez治疗。辉瑞退出病毒载体基因治疗辉瑞放弃Beqvez的决定，基本上标志着辉瑞退出了病毒载体递送的基因代替治疗领域。2023年7月，辉瑞将早期研发阶段的基因治疗卖给了阿斯利康旗下的罕见病部门Alexion。辉瑞随即放弃了该疗法的一切开发。2025年2月，辉瑞终止商业化的Beqvez。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-24/doc-inemqazp0162941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0321505439.SGD","SG9999003800.SGD","IE000M9KFDE8.USD","LU1883839398.USD","LU0306807586.USD","LU0225284248.USD","BK4599","LU1057294990.SGD","LU0225771236.USD","LU1066053197.SGD","BK4533","LU1894683348.USD","BK4581","IE00B19Z3581.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","SG9999002224.SGD","LU0170899867.USD","LU0456855351.SGD","BK4588","SG9999001176.USD","BK4585","BK4007","LU0985481810.HKD","SG9999002232.USD","LU1023059063.AUD","BK4534","LU1894683264.USD","BK4592","BK4568","LU0289739699.SGD","LU1066051498.USD","SGXZ57979304.SGD","PFE","LU0122379950.USD","LU0321505868.SGD","SG9999001176.SGD","LU0306806265.USD","SG9999013999.USD","SG9999011175.SGD","IE0002270589.USD","LU0058720904.USD","IE00BLSP4239.USD","BK4550","IE00B19Z3B42.SGD","LU0234572021.USD","LU0868494617.USD"],"gpt_icon":1},{"id":"2513965447","title":"一圖解碼：真實生物二度赴港IPO 阿茲夫定撐起主營收 虧損大幅收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2513965447","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513965447?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 10:32","pubTimestamp":1740364358,"startTime":"0","endTime":"0","summary":"2月18日，真实生物又一次向港交所递交了招股书，仍计划在主板挂牌上市；由中金公司担任独家保荐人。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202502_1/24cf4171-9c8d-4e8b-a8ed-242fe1fd5ec4.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202502_1/24cf4171-9c8d-4e8b-a8ed-242fe1fd5ec4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67bbda4623082954e50513d3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK4535","BK4568","BK4139","BK4551","BK4585","BNTX","BK4588","BK4548"],"gpt_icon":0},{"id":"2513626227","title":"吉利德科學(GILD.US)突破性小分子藥物獲歐盟批准 用於治療致命性肝病","url":"https://stock-news.laohu8.com/highlight/detail?id=2513626227","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513626227?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:07","pubTimestamp":1740359262,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，吉利德科学公司日前宣布，欧盟委员会已有条件批准seladelpar上市，与熊去氧胆酸联用，治疗对UDCA单药应答不足的原发性胆汁性胆管炎患者。Seladelpar已于2024年8月获得美国FDA的加速批准，用于治疗PBC。Seladelpar曾获得FDA授予的突破性疗法认定以及针对PBC患者的孤儿药资格，以及欧洲药品管理局授予的PRIME资格。作为FDA加速批准的一部分，吉利德承诺进行一项名为AFFIRM的确认性长期结局研究，该研究已在代偿期肝硬化患者中启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"吉利德科学(GILD.US)突破性小分子药物获欧盟批准 用于治疗致命性肝病","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1839511570.USD","BK4566","LU2087621335.USD","BK4588","LU1571399168.USD","IE00B19Z3B42.SGD","BK4139","BK4550","GILD","LU2468319806.SGD","LU0058720904.USD","IE0002270589.USD","LU0320765992.SGD","LU1430594728.SGD","LU0109394709.USD","BK4532","LU1066051498.USD","LU1585245621.USD","IE00B19Z3581.USD","LU0889565916.HKD","BK4585","BK4568","LU0234570918.USD","BK4583","IE00BKVL7J92.USD","LU1066053197.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","LU2089984988.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","BK4578","IE00B7SZLL34.SGD"],"gpt_icon":0}],"pageSize":16,"totalPage":10,"pageCount":9,"totalSize":146}]}}